Loading...
XLONSYNC
Market cap787mUSD
Dec 20, Last price  
99.80GBP
1D
0.20%
1Q
-9.27%
Jan 2017
-25.94%
IPO
-3.11%
Name

Syncona Ltd

Chart & Performance

D1W1MN
XLON:SYNC chart
P/E
16,537.71
P/S
982.74
EPS
0.01
Div Yield, %
0.00%
Shrs. gr., 5y
-0.12%
Rev. gr., 5y
-32.02%
Revenues
31m
P
66,172,79913,479,00055,300,0004,750,00083,162,000196,441,000439,118,000-167,305,00078,539,00018,693,000-39,791,00030,749,000
Net income
4m
P
61,315,2009,538,00049,678,000-1,000,00077,291,000172,831,000411,262,000-195,556,00053,158,0008,838,000-56,018,0003,788,000
CFO
20m
P
-633,6004,430,0005,411,0005,837,0007,116,0008,193,000300,00013,172,000-3,000262,000-265,00020,473,000
Dividend
Jun 20, 20190.023 GBP/sh
Earnings
Jun 18, 2025

Profile

Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
IPO date
Oct 26, 2012
Employees
1,208
Domiciled in
GG
Incorporated in
GG

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
30,749
-177.28%
(39,791)
-312.87%
18,693
-76.20%
Cost of revenue
39,253
15,000
17,540
Unusual Expense (Income)
NOPBT
(8,504)
(54,791)
1,153
NOPBT Margin
137.70%
6.17%
Operating Taxes
(4,634)
(4,250)
Tax Rate
NOPAT
(8,504)
(50,157)
5,403
Net income
3,788
-106.76%
(56,018)
-733.83%
8,838
-83.37%
Dividends
Dividend yield
Proceeds from repurchase of equity
(20,223)
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
2,861
13,757
23,545
Net debt
(1,241,959)
(1,258,269)
(1,323,508)
Cash flow
Cash from operating activities
20,473
(265)
262
CAPEX
Cash from investing activities
Cash from financing activities
(20,223)
FCF
(21,245)
(51,486)
6,183
Balance
Cash
261
11
276
Long term investments
1,241,698
1,258,258
1,323,232
Excess cash
1,240,422
1,260,259
1,322,573
Stockholders' equity
1,259,101
1,254,655
1,309,841
Invested Capital
10,675
8,459
ROIC
131.46%
ROCE
0.09%
EV
Common stock shares outstanding
666,854
668,575
672,988
Price
Market cap
EV
EBITDA
(8,504)
(54,791)
1,153
EV/EBITDA
Interest
Interest/NOPBT